Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections
The Pediatric Infectious Disease JournalPublished 22 September 2006
Shai Ashkenazi, André Vertruyen, Javier Ar stegui, Susanna Esposito, David Douglas McKeith, Timo Klemola
Citations313
SJR quartileQ1
SJR score0.78
SNIP0.76
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
CAIV-T was well tolerated in these children with a history of recurrent respiratory tract infections and demonstrated superior relative efficacy compared with TIV in preventing influenza illness.
Abstract
CAIV-T was well tolerated in these children with RTIs and demonstrated superior relative efficacy compared with TIV in preventing influenza illness.
Keywords
Medicine
New England Journal of MedicineThe Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in Children
1,099 Citations2000Kathleen M. Neuzil, Beverly G. Mellen +3 more
Healthy children younger than one year of age are hospitalized for illness attributable to influenza at rates similar to those for adults at high risk for influenza.
New England Journal of MedicineThe Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children
918 Citations1998Robert B. Belshe, Paul M. Mendelman +10 more
A live attenuated, cold-adapted, trivalent influenzavirus vaccine was safe, immunogenic, and effective against influenza A(H3N2) and B in healthy children.
The Journal of PediatricsEfficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
434 Citations2000Robert B. Belshe, William C. Gruber +15 more
This live attenuated, cold-adapted influenza vaccine was safe, immunogenic, and efficacious against influenza A/H3N2 (including a variant, A/Sydney, not contained in the vaccine) and influenza B.
JAMAEffectiveness of Inactivated Influenza Vaccine in Preventing Acute Otitis Media in Young Children
284 Citations2003Alejandro Hoberman, David P. Greenberg +12 more
Administration of inactivated trivalent influenza vaccine to children aged 6 to 24 months did not reduce their burden of AOM or their utilization of selected health care and related resources during peak influenza periods.
PEDIATRICSIncidence of Outpatient Visits and Hospitalizations Related to Influenza in Infants and Young Children
265 Citations2004Megan A. O’Brien, Timothy M. Uyeki +7 more
Estimates of outpatient visits for influenza will help quantify the potential health benefits and cost savings from influenza vaccination of healthy children aged 6 to 23 months.
The Pediatric Infectious Disease JournalEfficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience
226 Citations2001Kathleen M. Neuzil, William D. Dupont +2 more
Inactivated trivalent influenza A vaccines are well-tolerated and efficacious in the prevention of influenza A disease in children 1 to 16 years old.
The Pediatric Infectious Disease JournalSafety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents
166 Citations2004Randy Bergen, Steve Black +8 more
CAIV was generally safe in children and adolescents and the observation of an increased risk of asthma/reactive airway disease in children <36 months of age is of potential concern.
The Pediatric Infectious Disease JournalSafety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination
120 Citations2004Kenneth M. Zangwill, Robert B. Belshe
It is apparent that relatively few data are available on the safety of TIV in young children, that important age-specific differences in TIV vaccine efficacy exist and that LAIV appears similar to TIV with regard to safety and efficacy in younger children, but no head-to-head comparison of these two licensed products is available.
PEDIATRICSLive Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial
110 Citations2005Pedro A. Piedra, Manjusha Gaglani +7 more
The largest safety study to date of the recently licensed LAIV-T in children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a 4-year community-based trial that was conducted at Scott & White Memorial Hospital and Clinic.
Clinical Infectious DiseasesSafety, Efficacy, and Effectiveness of Live, Attenuated, Cold‐Adapted Influenza Vaccine in an Indicated Population Aged 5–49 Years
109 Citations2004Robert B. Belshe, Kristin L. Nichol +7 more
The present reanalysis summarizes data on the indicated uses for CAIV-T in the indicated population aged 5-49 years and reveals no significant difference between vaccine recipients and placebo recipients, with regard to acute respiratory events, acute gastrointestinal events, systemic bacterial infection, or rare events possibly related to influenza.
Archives of Disease in ChildhoodBurden of influenza in healthy children and their households
99 Citations2004N. Principi
In comparison with the influenza negative children, those who were influenza positive had an older mean age, were more often attending day care centres or schools, more frequently experienced fever and croup, received more antipyretics, and had a longer duration of fever and school absence.
Epidemiology and InfectionThe incidence of influenza-associated hospitalizations in children in Germany
80 Citations2002Josef Weigl, Wolfram Puppe +1 more
Cardiac conditions and asthma were the major risk factors for admission to hospital with influenza A and RSV and underlying conditions were most common in influenza B, and targeting children with underlying conditions in the German immunization programme is appropriate.
The Pediatric Infectious Disease JournalSafety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma
79 Citations2002Gregory J. Redding, Robert Walker +7 more
CAIV-T was generally safe and well-tolerated in children and adolescents with moderate to severe asthma and no serious adverse event occurred.
PharmacoEconomicsA Study of Influenza and Influenza-Related Complications among Children in a Large US Health Insurance Plan Database
62 Citations2003Jeanne Loughlin, Nick Poulios +3 more
Measures to prevent and treat influenza-related complications are certainly warranted for at-risk children, although the elevated incidence rates for several common complications even among healthy children should prompt consideration of these measures for all children.
The Pediatric Infectious Disease JournalInfluenza burden in children newborn to eleven months of age in a pediatric emergency department during the peak of an influenza epidemic
56 Citations2003Dominique Ploin, Sylviane Liberas +7 more
The results confirm the high prevalence of influenza-related morbidity in infants during the epidemic peak, and one child in three consulting to the pediatric emergency room had a virologically confirmed influenza infection regardless of the body temperature.
PubMedInfluenza surveillance--United States, 1992-93 and 1993-94.
48 Citations1997Lynnette Brammer, Keiji Fukuda +7 more
Activity rose during November and December and peaked earlier than usual, during the last week of December and the first week of January; influenza A(H3N2) viruses predominated during the 1993-94 influenza season.
Journal of Clinical MicrobiologyCocirculation and Evolution of Two Lineages of Influenza B Viruses in Europe and Israel in the 2001-2002 Season
48 Citations2003Xiaohang Chi, Trentice V. Bolar +3 more
The data trace the geographic spread of B/Victoria/2/87-like viruses and support the emergence of B/(Hong Kong/1351/02-like)like viruses, possibly due to selective advantages of reassortment.
Journal of Clinical MicrobiologyMolecular Evolution of Human Influenza A/H3N2 Virus in Asia and Europe from 2001 to 2003
31 Citations2005Xiaohang Chi, Trentice V. Bolar +4 more
Hemagglutinin sequences of 146 human influenza A/H3N2 strains identified in respiratory specimens from Asia and Europe during the 2001-2003 influenza seasons were analyzed by DNA sequencing and suggest four amino acid substitutions led to the antigenic conversion of the previously predominant A/Panama/2007/99-like strains.
The Pediatric Infectious Disease JournalInfluenza in children: the German perspective
25 Citations2003Johannes Förster
Direct and indirect epidemiologic evidence indicates that influenza is a significant health hazard for all children.